A Study to Investigate the Genetic Variation of Dopamine Pathway Associated With the Observed Effects of a New Treatment in Former Studies in Patients With Chronic Pain
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs T4P 1001 (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Tools4Patient
- 07 Jun 2017 Biomarkers information updated
- 24 Apr 2017 Planned End Date changed from 1 May 2017 to 1 Aug 2017.
- 24 Apr 2017 Planned primary completion date changed from 1 May 2017 to 1 Aug 2017.